EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 98 filers reported holding EPIZYME INC in Q3 2016. The put-call ratio across all filers is 7.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $0 | -100.0% | 105 | -99.6% | 0.00% | – |
Q1 2022 | $27,000 | -96.7% | 23,913 | -92.8% | 0.00% | – |
Q4 2021 | $828,000 | +21.1% | 331,060 | +147.6% | 0.00% | – |
Q3 2021 | $684,000 | -24.5% | 133,721 | +22.5% | 0.00% | – |
Q2 2021 | $906,000 | -42.1% | 109,116 | -39.3% | 0.00% | -100.0% |
Q1 2021 | $1,566,000 | +6.2% | 179,752 | +32.5% | 0.00% | 0.0% |
Q4 2020 | $1,474,000 | -15.6% | 135,710 | -7.3% | 0.00% | 0.0% |
Q3 2020 | $1,746,000 | +58.0% | 146,323 | +112.5% | 0.00% | 0.0% |
Q2 2020 | $1,105,000 | +99.8% | 68,860 | +93.5% | 0.00% | – |
Q1 2020 | $553,000 | -71.6% | 35,594 | -55.1% | 0.00% | -100.0% |
Q4 2019 | $1,950,000 | +283.9% | 79,259 | +61.2% | 0.00% | – |
Q3 2019 | $508,000 | -19.9% | 49,167 | -2.8% | 0.00% | – |
Q2 2019 | $634,000 | +78.6% | 50,563 | +76.9% | 0.00% | – |
Q1 2019 | $355,000 | +332.9% | 28,585 | +114.8% | 0.00% | – |
Q4 2018 | $82,000 | -69.4% | 13,307 | -47.4% | 0.00% | – |
Q3 2018 | $268,000 | -66.9% | 25,306 | -57.6% | 0.00% | – |
Q2 2018 | $809,000 | +232.9% | 59,656 | +335.1% | 0.00% | – |
Q1 2018 | $243,000 | -36.7% | 13,711 | -55.1% | 0.00% | – |
Q4 2017 | $384,000 | -27.8% | 30,555 | +9.4% | 0.00% | -100.0% |
Q3 2017 | $532,000 | +20.1% | 27,920 | -4.8% | 0.00% | – |
Q2 2017 | $443,000 | +54.4% | 29,330 | +75.9% | 0.00% | – |
Q1 2017 | $287,000 | +537.8% | 16,677 | +349.9% | 0.00% | – |
Q4 2016 | $45,000 | +542.9% | 3,707 | +365.7% | 0.00% | – |
Q3 2016 | $7,000 | +600.0% | 796 | +1249.2% | 0.00% | – |
Q2 2016 | $1,000 | -96.2% | 59 | -97.3% | 0.00% | – |
Q1 2016 | $26,000 | +160.0% | 2,166 | +228.2% | 0.00% | – |
Q4 2015 | $10,000 | -92.6% | 660 | -94.2% | 0.00% | – |
Q3 2015 | $136,000 | +946.2% | 11,333 | +1938.3% | 0.00% | – |
Q2 2015 | $13,000 | -23.5% | 556 | -37.5% | 0.00% | – |
Q1 2015 | $17,000 | -52.8% | 890 | -54.1% | 0.00% | – |
Q4 2014 | $36,000 | -69.2% | 1,940 | -55.3% | 0.00% | – |
Q3 2014 | $117,000 | -51.2% | 4,337 | -43.8% | 0.00% | – |
Q2 2014 | $240,000 | +87.5% | 7,722 | +33.3% | 0.00% | – |
Q1 2014 | $128,000 | +6300.0% | 5,794 | +4009.2% | 0.00% | – |
Q4 2013 | $2,000 | -77.8% | 141 | -36.5% | 0.00% | – |
Q3 2013 | $9,000 | 0.0% | 222 | -28.4% | 0.00% | – |
Q2 2013 | $9,000 | – | 310 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |